Clinical Trial Update: The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of steady-state BIA 9-1067 on Levodopa pharmacokinetics in Parkinson's disease; results have been posted after study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067
• levodopa (levodopa)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: COMPLETED | Results posted: 2016-09-20